Carl Zeiss Meditec AG: Effectiveness and efficiency of targeted intra-operative single dose radiotherapy for breast cancer patients confirmed
- Written by Reporters
New long-term results from the international TARGIT-A breast cancer study, based on ZEISS technology, have been published1
JENA, GERMANY - Newsaktuell - August 27, 2020 - Use of targeted intra-operative radiotherapy (TARGIT), as a single dose - with ZEISS INTRABEAM - directly after removal of a tumor, confirmed as non-inferior, when compared with...

